Borea Therapeutics
1 known investors
Borea Therapeutics develops therapies for patients with genetic or chronic diseases using next-generation viral vectors. Its proprietary click chemistry platform chemically modifies adeno-associated virus (AAV) vectors, based on research from the EMBL Institute.
BiotechDeep TechHealthtech
Investors · 1
In the news
Frequently asked questions
- What does Borea Therapeutics do?
- Borea Therapeutics develops therapies for patients with genetic or chronic diseases using next-generation viral vectors. Its proprietary click chemistry platform chemically modifies adeno-associated virus (AAV) vectors, based on research from the EMBL Institute.
- Who are Borea Therapeutics's investors?
- Borea Therapeutics's investors include Sofinnova Partners.